卵巢癌
- 造模剂
- 7,12-Dimethylbenz[a]anthracene
- N-Nitroso-N-methylurea
- 4-Vinylcyclohexene dioxide
- 卵巢癌类器官 [1] [2]
- Hydrocortisone
- Forskolin
- Nicotinamide
- Sodium Pyruvate
- Vitamin C
- Y-27632
- Doxycycline
- 获批药物
- Melphalan
- Bevacizumab
- Carboplatin
- Cisplatin
- Cyclophosphamide
- Doxorubicin HCl
- Gemcitabine HCl
- Topotecan HCl
- Olaparib
- Niraparib tosylate
- Paclitaxel
- Rucaparib Camsylate
- Thiotepa
- 化疗方案
-
- BEP/PEB
- Bleomycin sulfate
- Etoposide
- Cisplatin
-
- CARBOPLATIN-TAXOL
- Carboplatin
- Paclitaxel
-
- GEMCITABINE-CISPLATIN
- Gemcitabine HCl
- Cisplatin
- 免疫检查点抑制剂
- 抗血管生成 [3]
-
- FGFR
- Sorafenib
- Ponatinib
- Nintedanib
-
- Angiotensin
- Angiotensin II human Acetate
- Angiotensin
- Olmesartan
-
- Endothelin
- Zibotentan
- BQ-123
- Ambrisentan
-
- IL-8
- SB225002
- Aprepitant
-
- PDGFR
- Crenolanib
- Ripretinib
- DNA修复相关 [3]
-
- DNA Alkylator
- Melphalan
- Trabectedin
- Oxaliplatin
- Carboplatin
- Cyclophosphamide Monohydrate
-
- RAD51
- Amuvatinib
- RI-1
- RS-1
-
- BRCA1
- Bractoppin
- 铂类相关 [3]
- 靶向疗法 (A) [3] [4]
- 靶向疗法 (B) [3]
-
- PTEN
- VO-Ohpic trihydrate
- bpV
-
- CA-125/MUC16
- Oregovomab
- Abagovomab
- Sofituzumab
- Sofituzumab vedotin
-
- Notch
- Crenigacestat
- Limantrafin
-
- HSP90
- Ganetespib
- Apoptozole
- NMS-E973
- 靶向疗法 (C) [3]
-
- ERBB3/HER3
- Patritumab
- Seribantumab
- Lumretuzumab
- Patritumab deruxtecan
-
- AURKA
- Alisertib
- Tozasertib
- MLN8054
- mAb & ADC
-
- CA-125/MUC16
- Oregovomab
- Abagovomab
- Sofituzumab
- Sofituzumab vedotin
- 相关化合物库
- FDA-approved Anticancer Drug Library
- Anti-cancer Compound Library
- Anti-cancer Compound Library-Ⅱ
- Cambridge Cancer Compound Library
- Small Molecule Immuno-Oncology Compound Library
- DNA Damage/DNA Repair compound Library
- Angiogenesis Related compound Library
- MAPK Inhibitor Library
- Stem Cell Differentiation Compound Library
